Journal article icon

Journal article

Bisphosphonates to reduce bone fractures in stage 3B+ chronic kidney disease: a propensity score-matched cohort study

Abstract:

Background

Bisphosphonates are contraindicated in patients with stage 4+ chronic kidney disease. However, they are widely used to prevent fragility fractures in stage 3 chronic kidney disease, despite a lack of good-quality data on their effects.

Objectives

The aims of each work package were as follows. Work package 1: to study the relationship between bisphosphonate use and chronic kidney disease progression. Work package 2: to study the assoc... Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Files:
Publisher copy:
10.3310/hta25170

Authors


More by this author
Institution:
University of Oxford
Division:
MSD
Department:
NDORMS
Role:
Author
ORCID:
0000-0002-0940-9211
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Nuffield Department of Population Health
Role:
Author
ORCID:
0000-0002-5172-512X
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
NDORMS
Role:
Author
ORCID:
0000-0001-7908-1912
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
NDORMS
Role:
Author
Expand authors...
Publisher:
NIHR Journals Library Publisher's website
Journal:
Health Technology Assessment Journal website
Volume:
25
Issue:
17
Publication date:
2021-03-19
Acceptance date:
2019-03-19
DOI:
ISSN:
1366-5278
Source identifiers:
987435
Language:
English
Keywords:
Pubs id:
pubs:987435
UUID:
uuid:96cf8895-0041-4e3d-a23a-483dde311950
Local pid:
pubs:987435
Deposit date:
2019-04-03

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP